S100A9 and atherosclerosis: Collectively, multiple studies have reported the ability of CXCL16 (69–72) and S100A9 (73, 74) stimulate the infiltration of macrophages in atherosclerosis, promoting disease progression, suggesting that they also may be playing a synergistic role in promoting AVC progression.